---
category: news
title: "Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders"
abstract: "About PROGENICS Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find ... who require systemic anticancer therapy; and RELISTOR (methylnaltrexone bromide ..."
publishedDateTime: 2019-07-12T13:11:00Z
sourceUrl: https://www.marketwatch.com/press-release/progenics-announces-preliminary-voting-results-of-annual-meeting-of-shareholders-2019-07-12
type: article
score: 44
published: false

provider:
  name: MarketWatch
  id: marketwatch.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png
    width: 1200
    height: 630
    title: "Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders"
---
